Navigation Links
More than 850 abstracts received, record attendance expected at major bone congress
Date:2/19/2013

The International Osteoporosis Foundation (IOF) and ESCEO have announced that a record number of abstracts (850+) have been submitted to the European Congress on Osteoporosis & Osteoarthritis (ESCEO13-IOF) and the 3rd IOF-ESCEO Pre-Clinical Symposium.

Projections also indicate a record number of delegates, making the ESCEO13-IOF Congress a 'must-attend' forum for both clinical and translational research in the field, as well the world's largest and most vibrant educational bone event.

Hotel accommodation in Rome is in high demand. The organizers recommend early registration to ensure the accommodation of your choice.

Register and reserve your hotel accommodation at http://www.ecceo13-iof.org/register

The Scientific Committee, chaired by Professors Cyrus Cooper (IOF) and Ren Rizzoli (ESCEO), has set up a high-quality programme featuring a faculty of leading international bone experts and numerous thematic symposia to enhance the plenary sessions.

Researchers with an interest in translational bone research may also benefit from the 3rd IOF-ESCEO Pre-Clinical Symposium (free for ESCEO13-IOF delegates or only 150 EUR for Symposium alone). The Symposium will feature lectures by leading international investigators. View the programme at http://www.ecceo13-iof.org/pre-clinical-symposium

IOF and ESCEO look forward to welcoming clinicians and researchers from many areas of specialization including rheumatology, endocrinology, orthopaedics, gerontology, imaging, and other fields concerned with osteoporosis and osteoarthritis.

For complete information visit http://www.ecceo13-iof.org/


'/>"/>

Contact: L. Misteli
info@iofbonehealth.org
41-229-940-100
International Osteoporosis Foundation
Source:Eurekalert

Page: 1

Related biology news :

1. SSR 2013 Annual Meeting: Call for abstracts
2. Jurassic records warn of risk to marine life from global warming
3. Ancient teeth bacteria record disease evolution
4. Cyclone did not cause 2012 record low for Arctic sea ice
5. Survival of the prettiest: Sexual selection can be inferred from the fossil record
6. Analysis of Greenland ice cores adds to historical record and provide glimpse into climates future
7. Warmest spring on record causes earliest flowering ever observed in eastern U.S.
8. Medbox, Inc. Comments on Record Trading Day
9. Sea surface temperatures reach record highs on Northeast continental shelf
10. Chikyu sets a new world drilling-depth record of scientific ocean drilling
11. UF scientists find state record 87 eggs in largest python from Everglades
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2016)... The Department of Transport Management (DOTM) of ... project, for the , Supply and Delivery of ... Infrastructure , to Decatur , ... Management Solutions. Numerous renowned international vendors participated in the tendering ... selected for the most compliant and innovative solution. The contract ...
(Date:5/24/2016)... , May 24, 2016 Ampronix facilitates superior patient care by providing unparalleled ... medical LCD display is the latest premium product recently added to the range of ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
(Date:5/9/2016)... May 9, 2016 Elevay is ... to expanding freedom for high net worth professionals seeking ... today,s globally connected world, there is still no substitute ... ever duplicate sealing your deal with a firm handshake. ... by taking advantage of citizenship via investment programs like ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... --  EpiBiome , a precision microbiome engineering company, today ... from Silicon Valley Bank (SVB). The financing will allow ... drug development efforts, as well as purchase additional lab ... been an incredible strategic partner to us – one ... provide," said Dr. Aeron Tynes Hammack , EpiBiome,s ...
(Date:6/23/2016)... ... ... STACS DNA Inc., the sample tracking software company, today announced that Dr. Hays ... DNA as a Field Application Specialist. , “I am thrilled that Dr. Young ... DNA. “In further expanding our capacity as a scientific integrator, Hays brings a wealth ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
(Date:6/23/2016)... 2016 Andrew D ... http://doi.org/10.17925/OHR.2016.12.01.22 Published recently in ... from touchONCOLOGY, Andrew D Zelenetz , discusses ... care is placing an increasing burden on healthcare ... therapies. With the patents on many biologics expiring, ...
Breaking Biology Technology: